Lung Screen Uptake Trial: results from a single lung cancer screening round.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 32759387.
- Also identified by DOI 10.1136/thoraxjnl-2020-214703 and PMC identifier 7509385.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
The Lung Screen Uptake Trial tested a novel invitation strategy to improve uptake and reduce socioeconomic and smoking-related inequalities in lung cancer screening (LCS) participation. It provides one of the first UK-based 'real-world' LCS cohorts. Of 2012 invited, 1058 (52.6%) attended a 'lung health check'. 768/996 (77.1%) in the present analysis underwent a low-dose CT scan. 92 (11.9%) and 33 (4.3%) participants had indeterminate pulmonary nodules requiring 3-month and 12-month surveillance, respectively; 36 lung cancers (4.7%) were diagnosed (median follow-up: 1044 days). 72.2% of lung cancers were stage I/II and 79.4% of non-small cell lung cancer had curative-intent treatment.
Medical subject headings
- Carcinoma
- Early Detection of Cancer
- Lung Neoplasms
- Patient Acceptance of Health Care